ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 30 filers reported holding ANNOVIS BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,453,450 | -31.9% | 258,530 | +2.6% | 0.00% | – |
Q2 2023 | $3,601,509 | -3.7% | 252,030 | +3.9% | 0.00% | – |
Q1 2023 | $3,738,019 | +14.7% | 242,571 | 0.0% | 0.00% | – |
Q4 2022 | $3,257,728 | -1.9% | 242,571 | +0.0% | 0.00% | – |
Q3 2022 | $3,321,000 | +20.8% | 242,461 | 0.0% | 0.00% | – |
Q2 2022 | $2,750,000 | -15.0% | 242,461 | 0.0% | 0.00% | – |
Q1 2022 | $3,237,000 | -19.7% | 242,461 | +5.8% | 0.00% | – |
Q4 2021 | $4,029,000 | -44.7% | 229,155 | -0.1% | 0.00% | – |
Q3 2021 | $7,285,000 | -62.9% | 229,484 | +0.0% | 0.00% | – |
Q2 2021 | $19,637,000 | +378.7% | 229,453 | +56.1% | 0.00% | – |
Q1 2021 | $4,102,000 | – | 147,001 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 463,797 | $3,497,000 | 1.42% |
Worth Venture Partners, LLC | 119,538 | $901,000 | 0.71% |
Lokken Investment Group LLC | 32,211 | $243,000 | 0.22% |
Sterling Investment Advisors, Ltd. | 50,588 | $381,000 | 0.13% |
Modera Wealth Management, LLC | 43,846 | $331,000 | 0.03% |
Cannell & Co. | 10,000 | $75,000 | 0.00% |
Sowell Financial Services LLC | 1,529 | $12,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 14,286 | $108,000 | 0.00% |
BROWN ADVISORY INC | 14,942 | $113,000 | 0.00% |